Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids

N. Karoli, A. Rebrov (Saratov, Russia)

Source: Annual Congress 2002 - Pathophysiology of interstitial and vascular lung diseases
Session: Pathophysiology of interstitial and vascular lung diseases
Session type: Thematic Poster Session
Number: 3023
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russia). Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids. Eur Respir J 2002; 20: Suppl. 38, 3023

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of endothelial dysfunction at the patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 480s
Year: 2002

Systemic inflammation and endothelial dysfunction in patient with bronchial asthma
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008

Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008


Outcome of COPD exacerbations treated with and without oral steroids in relation to airway and systemic inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 283s
Year: 2005

Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008

The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

New markers of endothelial dysfunction in patients with bronchial asthma with and without pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008

Relationship between induced sputum eosinophilia and endothelial dysfunction in children with bronchial asthma
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009


Role of Pgp in corticosteroid sensitivity in patients with severe forms of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


The vasomotor form of endothelial dysfunction in patients with bronchial asthma and vasomotor rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

Inhaled corticosteroids and β2-agonists reduces imbalance in the cellular redox status in patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004

Endothelial dysfunction in patients with bronchial asthma with and without arterial hypertension
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Effect of oral and inhalation corticosteroids on osseous tissue condition for patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002

Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects
Year: 2007


Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy
Source: Annual Congress 2006 - New developments in the treatment and management of asthma
Year: 2006


Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005

Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids
Source: Eur Respir J 2010; 36: 503-508
Year: 2010